- Home
- PAVM vs SPRC Comparison
PAVM vs SPRC Comparison
Compare PAVM & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- SPRC
- Stock Information
- Founded
- PAVM 2014
- SPRC 2004
- Country
- PAVM United States
- SPRC Israel
- Employees
- PAVM N/A
- SPRC N/A
- Industry
- PAVM Medical/Dental Instruments
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- PAVM Health Care
- SPRC Health Care
- Exchange
- PAVM Nasdaq
- SPRC Nasdaq
- Market Cap
- PAVM 7.2M
- SPRC 6.3M
- IPO Year
- PAVM 2016
- SPRC N/A
- Fundamental
- Price
- PAVM $0.65
- SPRC $0.41
- Analyst Decision
- PAVM Strong Buy
- SPRC
- Analyst Count
- PAVM 1
- SPRC 0
- Target Price
- PAVM $19.00
- SPRC N/A
- AVG Volume (30 Days)
- PAVM 210.8K
- SPRC 11.5M
- Earning Date
- PAVM 03-25-2025
- SPRC 02-15-2025
- Dividend Yield
- PAVM N/A
- SPRC N/A
- EPS Growth
- PAVM N/A
- SPRC N/A
- EPS
- PAVM 0.53
- SPRC N/A
- Revenue
- PAVM $4,034,000.00
- SPRC $1,747,000.00
- Revenue This Year
- PAVM $52.90
- SPRC N/A
- Revenue Next Year
- PAVM $248.84
- SPRC N/A
- P/E Ratio
- PAVM $1.23
- SPRC N/A
- Revenue Growth
- PAVM 166.27
- SPRC N/A
- 52 Week Low
- PAVM $0.57
- SPRC $0.20
- 52 Week High
- PAVM $3.50
- SPRC $6.78
- Technical
- Relative Strength Index (RSI)
- PAVM 45.41
- SPRC 43.78
- Support Level
- PAVM $0.62
- SPRC $0.42
- Resistance Level
- PAVM $0.70
- SPRC $0.55
- Average True Range (ATR)
- PAVM 0.05
- SPRC 0.09
- MACD
- PAVM 0.01
- SPRC -0.04
- Stochastic Oscillator
- PAVM 61.20
- SPRC 4.71
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.